HROW logo

Harrow Health (HROW) EBITDA

Annual EBITDA

$9.95 M
+$13.06 M+420.89%

December 31, 2023

Summary

Performance

1-Year Change

+420.89%

3-Year Change

+185.13%

5-Year Change

+395.02%

15-Year Change

+195.73%

HROW EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.82%
HROW annual EBITDA is higher than 81.82% of companies in Healthcare sector

High & Low

All-time High

$9.95 M
HROW annual EBITDA is currently at an all-time high

3-Year Low

-$3.10 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
HROW previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 19, 2025
HROW next annual earnings announcement is scheduled for Mar 19, 2025

OtherHROWprofitabilitymetrics:

Annual Revenue

$130.19 M
HROW annual revenue is $130.19 million

Annual Net Income

-$24.41 M
HROW annual net profit is -$24.41 million

Annual EBIT

-$2.39 M
HROW annual earnings before interest & taxes is -$2.39 million

Annual EPS

-$0.75
HROW annual earnings per share is -$0.75

Quarterly EBITDA

$4.67 M
+$1.82 M+63.72%

September 30, 2024

Summary

Performance

3-Month Change

+63.72%

1-Year Change

-23.05%

3-Year Change

+176.85%

5-Year Change

-52.5%

HROW Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.9%
HROW quarterly EBITDA is higher than 78.9% of companies in Healthcare sector

High & Low

All-time High

$12.52 M
HROW quarterly EBITDA is currently -62.69% below its historical high of $12.52 million

3-Year Low

-$4.97 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
HROW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
HROW next earnings announcement is scheduled for Mar 19, 2025

OtherHROWprofitabilitymetrics:

Quarterly Revenue

$49.26 M
HROW quarterly revenue is $49.26 million

Quarterly Net Income

-$4.22 M
HROW quarterly net profit is -$4.22 million

Quarterly EBIT

$1.32 M
HROW quarterly earnings before interest & taxes is $1.32 million

Quarterly EPS

-$0.12
HROW quarterly earnings per share is -$0.12

TTM EBITDA

$1.06 M
-$1.40 M-56.78%

September 30, 2024

Summary

Performance

3-Month Change

-56.78%

1-Year Change

-93.04%

3-Year Change

+229.25%

5-Year Change

+681.97%

HROW TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.61%
HROW TTM EBITDA is higher than 76.61% of companies in Healthcare sector

High & Low

All-time High

$16.57 M
HROW TTM EBITDA is currently -93.57% below its historical high of $16.57 million

3-Year Low

-$3.10 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
HROW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
HROW next earnings announcement is scheduled for Mar 19, 2025

OtherHROWprofitabilitymetrics:

TTM Revenue

$169.14 M
HROW TTM revenue is $169.14 million

TTM Net Income

-$33.41 M
HROW TTM net profit is -$33.41 million

TTM EBIT

-$11.73 M
HROW TTM earnings before interest & taxes is -$11.73 million

TTM EPS

-$0.95
HROW TTM earnings per share is -$0.95

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$9.95 M
HROW annual EBITDA is $9.95 million

Annual Net Income

-$24.41 M
HROW annual net profit is -$24.41 million

Annual Interest Expense

$21.32 M
HROW annual interest expense is $21.32 million

Annual Income Tax

$701.00 K
HROW annual income tax is $701.00 thousand

Annual D&A

$12.34 M
HROW annual depreciation & amortization is $12.34 million

HROW EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+420.9%-23.1%-93.0%
3 y3 years+185.1%+176.8%+229.3%
5 y5 years+395.0%-52.5%+682.0%

HROW EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+420.9%-50.9%+194.0%-93.0%+134.3%
5 y5-yearat high+420.9%-52.5%+139.9%-93.6%+104.8%
alltimeall timeat high+170.0%-62.7%+139.9%-93.6%+104.8%

Harrow Health EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$4.67 M(+63.7%)
$1.06 M(-56.8%)
Jun 2024
-
$2.85 M(-157.4%)
$2.46 M(-45.1%)
Mar 2024
-
-$4.97 M(+233.8%)
$4.49 M(-54.9%)
Dec 2023
$9.95 M(-420.9%)
-$1.49 M(-124.5%)
$9.95 M(-34.9%)
Sep 2023
-
$6.07 M(+24.4%)
$15.30 M(+182.5%)
Jun 2023
-
$4.88 M(+892.1%)
$5.41 M(-286.0%)
Mar 2023
-
$492.00 K(-87.2%)
-$2.91 M(-6.2%)
Dec 2022
-$3.10 M(-172.8%)
$3.85 M(-201.1%)
-$3.10 M(-221.1%)
Sep 2022
-
-$3.81 M(+10.7%)
$2.56 M(+765.5%)
Jun 2022
-
-$3.44 M(-1244.2%)
$296.00 K(-90.7%)
Mar 2022
-
$301.00 K(-96.8%)
$3.18 M(-25.4%)
Dec 2021
$4.26 M(+22.0%)
$9.52 M(-256.6%)
$4.26 M(-616.9%)
Sep 2021
-
-$6.08 M(+981.5%)
-$824.00 K(-105.5%)
Jun 2021
-
-$562.00 K(-140.7%)
$15.09 M(-9.0%)
Mar 2021
-
$1.38 M(-68.8%)
$16.57 M(+374.8%)
Dec 2020
$3.49 M(+83.0%)
$4.43 M(-54.9%)
$3.49 M(-2007.7%)
Sep 2020
-
$9.83 M(+963.0%)
-$183.00 K(-99.1%)
Jun 2020
-
$925.00 K(-107.9%)
-$20.45 M(-8.3%)
Mar 2020
-
-$11.70 M(-1639.6%)
-$22.31 M(-1269.3%)
Dec 2019
$1.91 M(-156.6%)
$760.00 K(-107.3%)
$1.91 M(-434.2%)
Sep 2019
-
-$10.43 M(+1013.4%)
-$571.00 K(-105.9%)
Jun 2019
-
-$937.00 K(-107.5%)
$9.70 M(-7.4%)
Mar 2019
-
$12.52 M(-828.2%)
$10.47 M(-410.2%)
Dec 2018
-$3.37 M(-67.6%)
-$1.72 M(+929.3%)
-$3.37 M(+0.6%)
Sep 2018
-
-$167.00 K(+0.6%)
-$3.35 M(-38.8%)
Jun 2018
-
-$166.00 K(-87.4%)
-$5.48 M(-30.9%)
Mar 2018
-
-$1.32 M(-22.2%)
-$7.92 M(-23.8%)
Dec 2017
-$10.40 M(-26.6%)
-$1.70 M(-25.8%)
-$10.40 M(-11.6%)
Sep 2017
-
-$2.29 M(-12.3%)
-$11.76 M(-11.9%)
Jun 2017
-
-$2.61 M(-31.2%)
-$13.35 M(-7.2%)
Mar 2017
-
-$3.80 M(+23.9%)
-$14.39 M(+1.5%)
Dec 2016
-$14.17 M(-0.3%)
-$3.06 M(-21.1%)
-$14.17 M(-9.4%)
Sep 2016
-
-$3.88 M(+6.4%)
-$15.64 M(+3.5%)
Jun 2016
-
-$3.65 M(+1.9%)
-$15.12 M(+2.2%)
Mar 2016
-
-$3.58 M(-21.1%)
-$14.80 M(+4.1%)
Dec 2015
-$14.21 M
-$4.54 M(+35.1%)
-$14.21 M(+14.7%)
Sep 2015
-
-$3.36 M(+0.8%)
-$12.39 M(+8.0%)
DateAnnualQuarterlyTTM
Jun 2015
-
-$3.33 M(+11.3%)
-$11.47 M(+7.0%)
Mar 2015
-
-$2.99 M(+10.1%)
-$10.72 M(+6.5%)
Dec 2014
-$10.06 M(+31.7%)
-$2.72 M(+11.5%)
-$10.06 M(+9.1%)
Sep 2014
-
-$2.44 M(-5.4%)
-$9.23 M(+4.1%)
Jun 2014
-
-$2.58 M(+10.5%)
-$8.87 M(+4.2%)
Mar 2014
-
-$2.33 M(+24.0%)
-$8.50 M(+11.4%)
Dec 2013
-$7.64 M(+42.6%)
-$1.88 M(-9.5%)
-$7.64 M(+5.9%)
Sep 2013
-
-$2.08 M(-6.4%)
-$7.21 M(+13.0%)
Jun 2013
-
-$2.22 M(+51.4%)
-$6.38 M(+16.8%)
Mar 2013
-
-$1.46 M(+0.9%)
-$5.46 M(+2.0%)
Dec 2012
-$5.36 M(+509.6%)
-$1.45 M(+16.6%)
-$5.36 M(+28.9%)
Sep 2012
-
-$1.25 M(-4.3%)
-$4.16 M(+39.6%)
Jun 2012
-
-$1.30 M(-4.2%)
-$2.98 M(+63.4%)
Mar 2012
-
-$1.36 M(+436.8%)
-$1.82 M(+107.4%)
Dec 2011
-$878.60 K(-64.5%)
-$252.90 K(+280.3%)
-$878.70 K(-12.7%)
Sep 2011
-
-$66.50 K(-54.4%)
-$1.01 M(-39.7%)
Jun 2011
-
-$145.70 K(-64.8%)
-$1.67 M(-17.4%)
Mar 2011
-
-$413.60 K(+8.8%)
-$2.02 M(-18.5%)
Dec 2010
-$2.47 M(-45.6%)
-$380.20 K(-47.7%)
-$2.47 M(-13.5%)
Sep 2010
-
-$727.50 K(+46.5%)
-$2.86 M(-6.6%)
Jun 2010
-
-$496.50 K(-43.0%)
-$3.06 M(-19.3%)
Mar 2010
-
-$870.50 K(+13.7%)
-$3.80 M(-16.6%)
Dec 2009
-$4.55 M(+21.5%)
-$765.80 K(-17.6%)
-$4.55 M(-4.2%)
Sep 2009
-
-$929.00 K(-24.5%)
-$4.75 M(+2.0%)
Jun 2009
-
-$1.23 M(-24.4%)
-$4.66 M(-1.1%)
Mar 2009
-
-$1.63 M(+68.8%)
-$4.71 M(+25.6%)
Dec 2008
-$3.75 M(+31.0%)
-$964.10 K(+15.5%)
-$3.75 M(-13.6%)
Sep 2008
-
-$834.40 K(-34.8%)
-$4.34 M(+70.5%)
Jun 2008
-
-$1.28 M(+92.0%)
-$2.54 M(+101.3%)
Mar 2008
-
-$667.00 K(-57.1%)
-$1.26 M(+111.2%)
Dec 2007
-$2.86 M(>+9900.0%)
-$1.55 M(-260.3%)
-$598.10 K(-170.3%)
Sep 2007
-
$969.10 K(-9508.7%)
$851.00 K(-820.6%)
Aug 2007
-
-$10.30 K(+836.4%)
-$118.10 K(+9.6%)
May 2007
-
-$1100.00(-42.1%)
-$107.80 K(+1.0%)
May 2007
-$13.60 K
-
-
Feb 2007
-
-$1900.00(-98.2%)
-$106.70 K(+1.8%)
Nov 2006
-
-$104.80 K
-$104.80 K

FAQ

  • What is Harrow Health annual EBITDA?
  • What is the all time high annual EBITDA for Harrow Health?
  • What is Harrow Health annual EBITDA year-on-year change?
  • What is Harrow Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Harrow Health?
  • What is Harrow Health quarterly EBITDA year-on-year change?
  • What is Harrow Health TTM EBITDA?
  • What is the all time high TTM EBITDA for Harrow Health?
  • What is Harrow Health TTM EBITDA year-on-year change?

What is Harrow Health annual EBITDA?

The current annual EBITDA of HROW is $9.95 M

What is the all time high annual EBITDA for Harrow Health?

Harrow Health all-time high annual EBITDA is $9.95 M

What is Harrow Health annual EBITDA year-on-year change?

Over the past year, HROW annual EBITDA has changed by +$13.06 M (+420.89%)

What is Harrow Health quarterly EBITDA?

The current quarterly EBITDA of HROW is $4.67 M

What is the all time high quarterly EBITDA for Harrow Health?

Harrow Health all-time high quarterly EBITDA is $12.52 M

What is Harrow Health quarterly EBITDA year-on-year change?

Over the past year, HROW quarterly EBITDA has changed by -$1.40 M (-23.05%)

What is Harrow Health TTM EBITDA?

The current TTM EBITDA of HROW is $1.06 M

What is the all time high TTM EBITDA for Harrow Health?

Harrow Health all-time high TTM EBITDA is $16.57 M

What is Harrow Health TTM EBITDA year-on-year change?

Over the past year, HROW TTM EBITDA has changed by -$14.23 M (-93.04%)